Bildiri
Tam Metin Bildiri
Uluslararası
2018
Real world data on safety and efficacy of Ledipasvir Sofosbuvir ± RBV, Ombitasvir / Paritaprevir / Ritonavir ± Dasabuvir ± RBV combination therapy for chronic hepatitis C. A Turkey experience.
APASL Single Topic Conference
İstanbul · 27.09.2018–29.09.2018 · 27.09.2018
Sürdürülebilir Kalkınma Amaçları
-
SKA 3: Sağlıklı Bireyler
Atıf için künye
DEMİR, M., DANIŞ, N., KANİ, H. T., YILDIRIM, A. E., BALKAN, A., DEĞERTEKİN, M. B., YAPALI, S., GÜZELBULUT, F., DEMİRCAN, M., SOYLU, A., ÜÇBİLEK, E., YARAŞ, S., VATANSEVER, S., ÇALIŞKAN KARTAL, A., AKARSU, M., AKIN, M., KEFELİ, A., IRAK, K., Dursun, H., … İDİLMAN, R. (2018). Real world data on safety and efficacy of Ledipasvir Sofosbuvir ± RBV, Ombitasvir / Paritaprevir / Ritonavir ± Dasabuvir ± RBV combination therapy for chronic hepatitis C. A Turkey experience. APASL Single Topic Conference, İstanbul.
BibTeX
@inproceedings{demir2018-228274,
author = {DEMİR, MEHMET and DANIŞ, NİLAY and KANİ, HALUK TARIK and YILDIRIM, ABDULLAH EMRE and BALKAN, AYHAN and DEĞERTEKİN, MUSTAFA BÜLENT and YAPALI, SUNA and GÜZELBULUT, FATİH and DEMİRCAN, MELEK and SOYLU, ALİYE and ÜÇBİLEK, ENVER and YARAŞ, SERKAN and VATANSEVER, SEZGİN and ÇALIŞKAN KARTAL, AYSUN and AKARSU, MESUT and AKIN, METE and KEFELİ, AYŞE and IRAK, KADER and Dursun, Hakan and NURİYEV, KENAN and SÜMER, HALE and KACAR, SABİTE and İNCİ, İSMAİL and MERT, ALİ and POTUROĞLU, ŞULE and COŞAR, ARİF MANSUR and HTWAY, ZARNİ and GÖKTÜRK, HÜSEYİN SAVAŞ and ÖZENİRLER MAYER, SEREN and ŞEN, İLKER and AKBULUT, SABİYE and BALKAN, YASEMİN and KÖKLÜ, HAYRETTİN and ALADAĞ, MURAT and BAHÇECİOĞLU, İBRAHİM HALİL and ALKIM, HÜSEYİN and TEMEL, TUNCER and ÖZAKYOL, AYŞEGÜL and SENATES, EBUBEKİR and SEZGİN, ORHAN and ERSÖZ, GALİP and AKDOĞAN KAYHAN, MERAL and KARASU, ABDULLAH ZEKİ and GÜNŞAR, FULYA and AKYILDIZ, MURAT and BEŞIŞIK, SELMAN FATİH and DİNÇER, DİNÇ and ÖZDOĞAN, OSMAN and ÖRMECİ, NECATİ and YURTAYDIN, SÜLEYMAN CİHAN and KAYMAKOĞLU, SABAHATTİN and AKARCA, ULUS SALİH and İDİLMAN, RAMAZAN},
title = {Real world data on safety and efficacy of Ledipasvir Sofosbuvir ± RBV, Ombitasvir / Paritaprevir / Ritonavir ± Dasabuvir ± RBV combination therapy for chronic hepatitis C. A Turkey experience.},
booktitle = {APASL Single Topic Conference},
address = {İstanbul},
year = {2018},
url = {https://akademik.atauni.edu.tr/yayinlar/228274-real-world-data-on-safety-and-efficacy-of-ledipasvir-sofosbuvir-rbv-ombitasvir}
}